The association of SIPA1 gene polymorphisms with breast cancer risk: Evidence from published studies

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 441-445

  Yi, Sheng Ming ^a   Li, Gui Yuan ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Breast cancer; Meta analysis; SIPA1

Indexed keywords

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER RISK; CANCER SUSCEPTIBILITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ONCOGENE; PRIORITY JOURNAL; SIPA1 GENE; ASIAN; CASE CONTROL STUDY; CAUCASIAN; ETHNICITY; GENE FREQUENCY; GENETIC CODE; GENETIC HETEROGENEITY; PROMOTER REGION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

ALLELES; BREAST NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GTPASE-ACTIVATING PROTEINS; HUMANS; NUCLEAR PROTEINS; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84957812232     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1061-z     Document Type: Article

References (14)

1. Thavarajah N, Wong K, Zhang L, et al. Continued success in providing timely palliative radiation therapy at the Rapid Response Radiotherapy Program: a review of 2008-2012. Curr Oncol. 2013;20(3):e206-11.
2. Hou J, Jiang Y, Tang W, Jia S. p53 codon 72 polymorphism and breast cancer risk: a meta-analysis. Exp Ther Med. 2013;5(5):1397-402.
3. Dahabreh IJ, Schmid CH, Lau J, et al. Genotype misclassification in genetic association studies of the rs1042522 TP53 (Arg72Pro) polymorphism: a systematic review of studies of breast, lung, colorectal, ovarian, and endometrial cancer. Am J Epidemiol. 2013;177(12):1317-25.
4. Alsaif AA, Hasan TN, Shafi G, et al. Association of multiple drug resistance-1 gene polymorphism with multiple drug resistance in breast cancer patients from an ethnic Saudi Arabian population. Cancer Epidemiol. 2013. doi:10.1016/j.canep.2013.04.011.
5. Luo T, Chen L, He P, et al. Vascular endothelial growth factor (VEGF) gene polymorphisms and breast cancer risk in a Chinese population. Asian Pac J Cancer Prev. 2013;14(4):2433-7.
6. Pei R, Xu Y, Wei Y, et al. Association of SIPA1 545 C>T polymorphism with survival in Chinese women with metastatic breast cancer. Front Med. 2013;7(1):138-42. doi:10.1007/s11684-013-0247-5.
7. Ji K, Ye L, Toms AM, et al. Expression of signal-induced proliferation-associated gene 1 (SIPA1), a RapGTPase-activating protein, is increased in colorectal cancer and has diverse effects on functions of colorectal cancer cells. Cancer Genomics Proteomics. 2012;9(5):321-7.
8. Packer BR, Yeager M, Burdett L, et al. SNP500Cancer: a public resource for sequence validation, assay development, and frequency analysis for genetic variation in candidate genes. Nucleic Acids Res. 2006;34:D617-21.
9. Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR. Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility. BMC Cancer. 2009;9:331. doi:10.1186/1471-2407-9-331.
10. Liu F,Wu Y, Xu Y, et al. Association of Sipa1-545(C/T)polymorphism with breast cancer risk and tumor characteristics in Chinese women. Zhong Guo Zhong Liu Lin Chuang. 2009;36:1183-5.
11. GaudetMM, Hunter K, Pharoah P, et al. Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. Int J Cancer. 2009;124(7):1716-20.
12. Park YG, Zhao X, Lesueur F, et al. Sipa1 is a candidate for underlying themetastasis efficiencymodifier locusMtes1. Nat Genet. 2005;37(10):1055-62.
13. Threadgill DW. Metastatic potential as a heritable trait. Nat Genet. 2005;37:1026-7.
14. Petitti DB. Approaches to heterogeneity in meta-analysis. Stat Med. 2001;20:3625-33.